Emerging therapeutic targets in parasitic protozoa

Bibliography

• CROFT SL: The current status of antiparasite chemotherapy. Parasitology (1997) 114(Suppl.):S3–S15.
   Google Scholar
• ••This supplement to Parasitology contains a collection of excellent articles derived from aBritish Society of Parasitology Symposium in London, 1996. Many of the articles have been quoted in this review and give a deeper insight into some areas merely touched on here. See [1, 25, 32, 68, 99, 115, 1421.
   Google Scholar
• KASPER LH, BUZONIGATEL D: Some opportunistic parasitic infections in AIDS: candidiasis, pneumocystosis, cryptosporidiosis, toxoplasmosis. Parasitol. Today (1998) 14:150–156.
   PubMedGoogle Scholar
• DAMIAN RT: Parasite immune evasion and exploitation: reflections and projections. Parasitology (1997) 115 (Suppl.):S169–S175.
   Google Scholar
• FOSTER S: Economic prospects for a new antimalarial drug. Trans. R. Soc. Trop. Med. Hyg. (1994) 88\(Suppl. 1):55–56.
   PubMed Web of Science ®Google Scholar
• KRISHNA S, WHITE NJ: Pharmacokinetics of quinine, chloroquine and amodiaquine-clinical implications. Clin. Pharmacokinetics (1996) 30:263–299.
   PubMed Web of Science ®Google Scholar
• WHITE NJ, NOSTEN F: Advances in chemotherapy and prophylaxis of malaria. Curr. Opin. Infect. Dis. (1993) 6:323–330.
   Web of Science ®Google Scholar
• •
   Google Scholar
• SU XZ, KIRKMAN LA, FUJIOKA H, WELLEMS TE: Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant Plasmodium fakiparum in Southeast Asia and Africa. Cell (1997) 91:593–603.
   PubMed Web of Science ®Google Scholar
• ••The work from WeItems' laboratory culminating in this genetic discovery of the chloroquinelocus is seminal to the field. However, recent data, not yet published, suggest that the mutations reported in the CG2 gene may not alone confer resistance.
   Google Scholar
• ROSENTHAL PJ, MESHNICK SR: Hemoglobin catabolism and iron utilization by malaria parasites. Mol. Biochem. Parasitol. (1996) 83:131–139.
   PubMed Web of Science ®Google Scholar
• WARD SA, BRAY PG, HAWLEY SR: Quinoline resistance mechanisms in Plasmodium fakiparum: the debate goes on. Parasitology (1997) 114(Suppl.):5125–5136.
   Google Scholar
• RIDLEY RG: Malaria: dissecting chloroquine resistance. Curr. Biol. (1998) 8:R346–R349.
   PubMed Web of Science ®Google Scholar
• SIMS P, WANG P, HYDE JE: On the efficacy of antifolate antimalarial combinations in Africa. Parasitol. Today (1998) 14: 136–137.
   Google Scholar
• VARIOUS: Artemisinin. Roy. Soc. Trop. Med. Hyg. (1994) 88\(Suppl. 1):1–64.
   PubMed Web of Science ®Google Scholar
• PEPIN J, MILORD F: The treatment of human African trypanosomiasis. Adv. Parasitol. (1994) 33:1–47.
   PubMed Web of Science ®Google Scholar
• •
   Google Scholar
• BARRETT MP, FAIRLAMB AH: The biochemical basis of arsenical-diamidine cross-resistance in African trypanosomes. Parasitol. Today (In press).
   Google Scholar
• VANGOMPEL A, VERVOORT T: Chemotherapy of leishmaniasis and trypanosomiasis. Curr. Opin. Infect. Dis. (1997) 10:469–474.
   Web of Science ®Google Scholar
• COUKELL AJ, BROGDEN RN: Liposomal amphotericin B-therapeutic use in the management of fungal infections and visceral leishmaniasis. Drugs (1998) 55:585–612.
   PubMed Web of Science ®Google Scholar
• YOSHIDA N, SCHENKMAN S: American trypanosomiasis. Curr. Opin. Infect. Dis. (1997) 10:351–356.
   Web of Science ®Google Scholar
• HABERKORN A: Chemotherapy of human and animal coccidioses-state and perspectives. Parasitol. Res. (1996) 82:193–199.
   PubMed Web of Science ®Google Scholar
• GUTTERIDGE WE: Chemotherapy. In: Modern Parasitology. Cox FEG (Ed.), Blackwell, Oxford (1993):219–242.
   Google Scholar
• CAMPBELL WC, REW RS: Chemotherapy of Parasitic Diseases. Plenum, New York (1986):655.
   Google Scholar
• FREEMAN CD, KLUTMAN NE, LAMP KC: Metronidazole-a therapeutic review and update. Drugs (1997) 54:679–708.
   PubMed Web of Science ®Google Scholar
• KATIYAR SK, GORDON VR, MCLAUGHLIN GL, EDLIND TD: Antiprotozoal activities of benzimidazoles and correlations with 13-tubulin sequence. Antimicrob. Agents Chemother. (1994) 38:2086–2090.
   PubMed Web of Science ®Google Scholar
• http: //www.dbbm.fiocruz.br/genome/parasite-genome/pgsummary.html
   Google Scholar
• KELLY JM: Genetic transformation of parasitic protozoa. Adv. Parasitol. (1997) 39:227–270.
   PubMed Web of Science ®Google Scholar
• WANG CC: Validating targets for antiparasite chemotherapy. Parasitology (1997)114(Suppl.):S31–S44.
   Google Scholar
• BARRETT MP, COOMBS GH, MOTTRAM JC: Recent advances in identifying and validating drug targets in trypanosomes and leishmania. Trends Microbiol. (In press).
   Google Scholar
• BELL A: Microtubule inhibitors as potential antimalarial agents. Parasitol. Today (1998) 14:234–240.
   PubMedGoogle Scholar
• VIAL H, ANCELIN ML, CALAS M et al.: Plasmodium phospholipid metabolism: a target for the development of novel antimalarial drugs. Ann. Trop. Med. Parasitol. (1997) 91 (Suppl.):S87–S90.
   Google Scholar
• KIRK K, STRANGE K: Functional properties and physiological roles of organic solute channels. Ann. Rev. Physiol. (1998) 60:719–739.
   PubMed Web of Science ®Google Scholar
• ANCELIN ML, CALAS M, BOMPART J et al.: Antimalarial activity of 77 phospholipid polarhead analogs: close correlation between inhibition of phospholipid metabolism and in vitro Plasmodium falciparum growth. Blood (1998) 91:1426–1437.
   PubMed Web of Science ®Google Scholar
• RAMOS H, VALDIVIESO E, GAMARGO M, DAGGER F, COHEN BE: Amphotericin-B killsunicellular leishmanias by forming aqueous pores permeable to small cations and anions. J. Memb. Biol. (1996) 152:65–75.
   PubMed Web of Science ®Google Scholar
• URBINA JA: Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastidparasites. Parasitololgy (1997) 114(Suppl.):591–599.
   Google Scholar
• URBINA JA, PAYARES G, MOLINA J et al.: Cure of short-and long-term experimental Chagas' disease using D0870. Science (1996) 273:969–971.
   PubMed Web of Science ®Google Scholar
• CROFT SL, SNOWDON D, YARDLEY V: The activities of four anticancer alkyllsophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. J. Antimicrob. Chemother. (1996) 38:1041–1047.
   PubMed Web of Science ®Google Scholar
• WELBURN SC, BARCINSKI MA, WILLIAMS GT: Programmed cell death in trypanosomatids. Parasitol. Today (1997) 13:22–26.
   PubMedGoogle Scholar
• FIELD H, FIELD MC: Tandem duplication of rah genes followed by sequence divergence and acquisition of distinct functions in Trypanosoma ', meet J. Biol. Chem. (1998) 272:10498–10505.
   Web of Science ®Google Scholar
• GRANT KM, HASSAN P, ANDERSON JM, MOTTRAM JC: The crk3 gene of Leishmania mexicana encodes a stage-regulated cdc2-related histone H1 kinase that associates with pl2cks1. J. Biol. Chem. (1998) 273:10153–10159.
   PubMed Web of Science ®Google Scholar
• MARTIN W, MULLER M: The hydrogen hypothesis for the first eukaryote. Nature (1998) 392:37–41.
   PubMed Web of Science ®Google Scholar
• SHAPIRO TA, ENGLUND PT: The structure and replication of kinetoplast DNA. Ann. Rev. Microbiol. (1995) 49:117–143.
   PubMed Web of Science ®Google Scholar
• STUART K, ALLEN TE, HEIDMANN S, SEIWERT SD: RNA editing in kinetoplastid protozoa. Microbiol. Mol. Biol. Rev. (1997) 61:105–120.
   PubMed Web of Science ®Google Scholar
• ••One of many excellent reviews covering the extraordinary process of RNA editing.
   Google Scholar
• SHAPIRO TA: Inhibition of topoisomerases in African trypanosomes. Acta Trop. (1993) 54:251–260.
   PubMed Web of Science ®Google Scholar
• WILKES JM, MULUGETA W, WELLS C, PEREGRINE AS: Modulation of mitochondrial electrical potential: a candidate mechanism for drug resistance in African trypanosomes. Biochem. J. (1997) 326:755–761.
   PubMed Web of Science ®Google Scholar
• WILSON RJM, WILLIAMSON DH: Extrachromosomal DNA in the Apicomplexa. Microbiol. Mol. Biol. Rev. (1997) 61:1–16.
   PubMed Web of Science ®Google Scholar
• •An excellent review covering an expanding field of interest.
   Google Scholar
• VAIDYA AB, LASHGARI MS, POLOGE LG, MORRISEY J: Structural features of Plasmodium cytochrome b that may underlie susceptibility to 8-aminoquinolines and hydroxynaphthoquinones. Mol. Biochem. Parasitol. (1993) 58:33–42.
   PubMed Web of Science ®Google Scholar
• HACKSTEIN JHP, MACKENSTEDT U, MEHLHORN H et al.: Parasitic apicomplexans harbor a chlorophyll a-D1 complex, the potential target for therapeutic triazines. Parasitol. Res. (1995) 81:207–216.
   PubMed Web of Science ®Google Scholar
• BECKERS CJM, ROOS DS, DONALD RGK et al.: Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii: implications for the target of macrolide antibiotics. J. Clin. Invest. (1995) 95:367–376.
   PubMed Web of Science ®Google Scholar
• FICHERA ME, BHOPALE MK, ROOS DS: In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii. Antimicrob. Agents Chemother. (1995) 39:1530–1537.
   PubMed Web of Science ®Google Scholar
• GARDNER MJ, WILLIAMSON DH, WILSON JM: A circular DNA in malaria parasites encodes an RNA polymerase like that of prokaryotes and chloroplasts. Mol. Biochem. Parasitol. (1991) 44:115–123.
   PubMed Web of Science ®Google Scholar
• FICHERA ME, ROOS DS: A plastid organelle as a drug target in apicomplexan parasites. Nature (1997) 390:407–409.
   PubMed Web of Science ®Google Scholar
• ROBERTS F, ROBERTS CW, JOHNSON JJ et al.: Evidence for the shikimate pathway in apicomplexan parasites. Nature (1998) 393:801–805.
   PubMed Web of Science ®Google Scholar
• ••A recent paper showing the presence of the shikimate pathway in apicomplexan parasitesand pointing to a possible widespread antimicrobial target.
   Google Scholar
• OPPERDOES FR: Compartmentation of carbohydrate metabolism in trypanosomes. Ann. Rev. Microbiol. (1987) 41:127–151.
   PubMed Web of Science ®Google Scholar
• COOMBS GH, DENTON H, BROWN SMA, THONG KW: Biochemistry of the coccidia. Adv. Parasitol. (1997) 39:141–226.
   PubMed Web of Science ®Google Scholar
• ••The definitive review on coccidian biochemistry.
   Google Scholar
• COOMBS GH, MULLER M: Energy metabolism of anaerobic protozoa. In: Biochemistry and Molecular Biology of Parasites. Marr JJ, Muller M (Eds.), Academic Press, London (1995) 33–47.
   Google Scholar
• COOMBS GH: Cryptosporidium parvum: biochemical peculiarities and drug targets. Parasitol. Today (In press).
   Google Scholar
• VIAL H: Recent developments and rationale towards new strategies for malarial chemotherapy. Parasite (1996) 3:3–23.
   PubMedGoogle Scholar
• •An excellent overview of Plasmodium biochemistry from the perspective of potential drug targets.
   Google Scholar
• CLAYTON CE, MICHELS P: Metabolic compartmentation in African trypanosomes. Parasitol. Today (1996) 12:465–471.
   Google Scholar
• •A recent summary of our understanding of the compartmentalisation of different aspects of trypanosomatid glucose metabolism and description of the glycosome. See also [51] for an older, but excellent, historical perspective.
   Google Scholar
• EISENTHAL R, CORNISH-BOWDEN A: Prospects for antiparasitic drugs-the case of Trypanosoma brucei, the causative agent of African sleeping sickness. J. Biol. Chem. (1998) 273:5500–5505.
   Google Scholar
• POLLAKIS G, GRADY RW, DIECK HA, CLARKSON AB: Competition between inhibitors of the trypanosome alternative coddase (TAO) and reduced coenzyme Q(9). Biochem. Pharmacol. (1995) 50:1207–1210.
   PubMed Web of Science ®Google Scholar
• CLARKSON AB, BROHN FH: Trypanosomiasis: an approach to chemotherapy by the inhibition of carbohydrate metabolism. Science (1976) 194:204–206.
   PubMed Web of Science ®Google Scholar
• BRINGAUD F, BALTZ D, BALTZ T: Functional and molecular characterization of a glycosomal PPI-dependent enzyme in trypanosomatids: pyruvate, phosphate dikinase. Proc. Natl. Acad. Sci. USA (1998) 95:7963–7968.
   PubMed Web of Science ®Google Scholar
• CAZZULO JJ: Aerobic fermentation of glucose by trypanosomatids. FASEB J. (1992) 6:3153–3161.
   PubMed Web of Science ®Google Scholar
• CAZZULO JJ: Intermediate metabolism in Trypanosoma cruzi. J. Bioenerg. Biomemb. (1994)26:157–165.
   PubMed Web of Science ®Google Scholar
• TIELENS AGM, VAN HELLEMOND JJ: Differences in energy metabolism between trypanosomatidae. Parasitol. Today (1998) 14:265–271.
   PubMedGoogle Scholar
• ••This review summarises other aspects of glucose metabolism in trypanosomatids which tendto get overlooked in a great deal of literature focusing on the glycosome.
   Google Scholar
• BZICK DJ, FOX BA, GONYER K: Expression of Plasmodium falciparum lactate dehydrogenase in Escherichia coli. Mol. Biochem. Parasitol. (1993) 59:155–166.
   PubMed Web of Science ®Google Scholar
• YANG SM, PARMLEY SF: A bradyzoite stage specifically expressed gene of Toxoplasma gondii encodes a polypeptide homologous to lactate dehydrogenase. Mol. Biochem. Parasitol. (1995) 73:291–294.
   PubMed Web of Science ®Google Scholar
• DENTON H, BROWN SMA, ROBERTS CW et al.: Comparison of the phosphofructokinase and pyruvate kinase activites of Cryptosporidium parvum, Eimeria tenella and Toxoplasma Mol. Biochem. Parasitol. (1996) 76:23–29.
   Web of Science ®Google Scholar
• PENG ZY, MANSOUR JM, ARAUJO F et al.: Some phosphonic analogs as inhibitors of pyrophosphate-dependent phosphofructokinase, a novel target in Toxoplasma Biochem. Pharmacol. (1995) 49:105–113.
   PubMed Web of Science ®Google Scholar
• SCHMATZ DM: The mannitol cycle in Eimeria. Parasitology (1997) 114 (Suppl.):S81–S89.
   Google Scholar
• ••Well-written summary of an unusual aspect of biochemistry in coccidia.
   Google Scholar
• LIBERATOR P, ANDERSON J, FEIGLIN M et al.: Molecular cloning and functionalexpression of mannitol-1-phosphatase from the apicomplexan parasite Eimeria tenella. J. Biol. Chem. (1998) 273:4237–4244.
   PubMed Web of Science ®Google Scholar
• MULLER M: Energy metabolism of protozoa without mitochondria. Ann. Rev. Microbiol. (1988) 42:465–488.
   PubMed Web of Science ®Google Scholar
• BARRETT MP: The pentose phosphate pathway and parasitic protozoa. Parasitol. Today (1997) 13:11–16.
   PubMedGoogle Scholar
• ROSEMEYER MA: The biochemistry of glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase and glutathione reductase. Cell. Biochem. Funct. (1987) 5:79–95.
   PubMed Web of Science ®Google Scholar
• HANAU S, RIPPA M, BERTELLI M, DALLOCCHIO F, BARRETT MP: 6-Phosphogluconate dehydrogenase from Trypanosoma brucei: kinetic analysis and inhibition by trypanocidal drugs. Eur. J. Biochem. (1996) 240:592–599.
   PubMedGoogle Scholar
• PARKIN DW: Purine-specific nucleoside ribohydrolase from Trypanosoma brucei brucei-purification, specificity and kinetic mechanism. J. Biol. Chem. (1998) 271:21713–21719.
   Web of Science ®Google Scholar
• HASSAN HF, COOMBS GH: Purine and pyrimidine metabolism in parasitic protozoa. FEMS Microbiol. Rev. (1988) 54:47–84.
   Google Scholar
• ULLMAN B, CARTER D: Hypoxanthine-guanine phosphoribosyltransferase as a therapautic target in protozoal infections. Infect. Agents Dis. (1995) 4:29–40.
   PubMedGoogle Scholar
• HWANG H-Y, ULLMAN B: Genetic analysis of purine metabolism in Leishmania donovani. J. Biol. Chem. (1997) 272:19488–19496.
   PubMed Web of Science ®Google Scholar
• ••A very good technical study into the effects of removing genes encoding some enzymes ofpurine metabolism from Leishmania. Results are not always as expected!
   Google Scholar
• BERENS RL, KRUG EC, MARR JJ: Purine and pyrimidine metabolism. In: Biochemistry and Molecular Biology of Parasites. Marr JJ, Muller M (Eds.), Academic Press, London (1995):89–117.
   Google Scholar
• WHITBY FG, LUECKE H, KUHN P et al.: Crystal structure of Tritrichomonas foetus inosine-5'-monophosphate dehydrogenase and the enzyme-product complex. Biochemistry (1997) 36:10666–10674.
   PubMed Web of Science ®Google Scholar
• BECK JT, WANG CC: The hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus has unique properties. Mol. Biochem. Parasitol. (1993) 60:187–194.
   PubMed Web of Science ®Google Scholar
• SOMOZA JR, CHIN MS, FOCIA PJ, WANG CC, FLETTERICK RJ: Crystal structure of the hypoxanthine-guanine-xanthine phosphoribosyltransferase from the protozoan parasite Tritrichomonas foetus. Biochemistry (1996) 35:7032–7040.
   PubMed Web of Science ®Google Scholar
• MUNAGALA NR, CHIN MS, WANG CC: Steady-state kinetics of the hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus: the role of threonine-47. Biochemistry (1998) 37:4045–4051.
   PubMed Web of Science ®Google Scholar
• MARR JJ: Purine metabolism in parasitic protozoa and its relationship to chemotherapy. In: Biochemical Protozoology. Coombs GH, North MJ (Eds.), Taylor & Francis, London (1991):524–536.
   Google Scholar
• LESTER SJ, KENYON JE: Use of allopurinol to treat visceral leishmaniasis in a dog. J. Am. Vet. Med. Assoc. (1996) 209:615–617.
   PubMed Web of Science ®Google Scholar
• HAMMOND DJ, GUTTERIDGE WE, OPPERDOES FR: A novel location for two enzymes of de novo pyrimidine biosynthesis in trypanosomes and Leishmania. FEBS Lett. (1981) 28:27–29.
   Google Scholar
• SEYMOUR KK, LYONS SD, PHILLIPS L, RIECKMANN KH, CHRISTOPHERSON RI: Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum. Biochemistry (1994) 33:5268–5274.
   PubMed Web of Science ®Google Scholar
• HUDSON AT: Atovaquone -a novel broad-spectrum anti-infective drug. Parasitol. Today (1993) 9:66–68.
   PubMedGoogle Scholar
• KRUNGKRAI J: Purification, characterization and localization of mitochondrial dihydroorotate dehydrogenase in Plasmodium falciparum, human malaria parasite. Biochem. Biophys. Acta (1995) 1243:351–360.
   PubMed Web of Science ®Google Scholar
• IVANETICH KM, SANTI DV: Bifunctional thymidylate synthase-dihydrofolate reductase in protozoa. FASEB J. (1990) 4:1591–1597.
   PubMed Web of Science ®Google Scholar
• FOOTE SJ, GALATIS D, COWMAN AF: Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc. Natl. Acad. Sci. USA (1990) 87:3014–3017.
   PubMed Web of Science ®Google Scholar
• HEKMATNEJAD M, RATHOD PK: Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase. Exp. Parasitol. (1997) 87:222–228.
   PubMed Web of Science ®Google Scholar
• TRIGLIA T, MENTING JGT, WILSON C, COWMAN AF: Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA (1997) 94:13944–13949.
   PubMed Web of Science ®Google Scholar
• BROOKS DR, WANG P, READ M et al.: Sequence variation of the hydroxymethyl-dihydropterin-pyrophosphokinase-dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur. J. Biochem. (1994) 224:397–405.
   PubMedGoogle Scholar
• NARE B, HARDY LW, BEVERLEY SM: The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major. J. Biol. Chem. (1997) 272:13883–13891.
   PubMed Web of Science ®Google Scholar
• NARE B, LUBA J, HARDY LW, BEVERLEY SM: New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity. Parasitology (1997) 114 (Suppl.):S101–S110.
   Google Scholar
• ••Another of the collection of articles in the Parasitologysupplement bringing us up to date withinformation on the status of antifolate chemotherapy aimed at Leishmania.
   Google Scholar
• DARKINRATTRAY SJ, GURNETT AM, MYERS RW et al.: Apicidin-a novel antiprotozoal agent that inhibits parasite histone deacetylase. Proc. Natl. Acad. Sci. USA (1996) 93:13143–13147.
   PubMed Web of Science ®Google Scholar
• SINGH SB, ZINK DL, POLISHOOK JD et al.: Apicidins-novel cyclic tetrapeptides as coccidiostats and antimalarial agents from Fusarium pallidoroseum. Tetrahedron Lett. (1996) 37:8077–8080.
   Web of Science ®Google Scholar
• VANHAMME L, PAYS E: Control of gene-expression in trypanosomes. Microbiol. Rev. (1995) 59:223–240.
   PubMedGoogle Scholar
• TOULME JJ, BOURGET C, COMPAGNO D, YURCHENKO L: Control of gene expression in viruses and protozoan parasites by antisense oligonucleotides. Parasitology (1997) 114(Suppl.):S45–S59.
   Google Scholar
• MEHLOTRA RK: Antioxidant defense mechanisms in parasitic protozoa. Crit. Rev. Microbiol. (1996) 22:295–314.
   PubMed Web of Science ®Google Scholar
• BEUTLER E: G6PD deficiency. Blood (1994) 84:3613–3636.
   PubMed Web of Science ®Google Scholar
• ATAMNA H, PASCARMONA G, GINSBURG H: Hexose-monophosphate shunt activity in intact Plasmodium falciparum-infected erythrocytes and in free parasites. Mol. Biochem. Parasitol. (1994) 67:79–89.
   PubMed Web of Science ®Google Scholar
• O'BRIEN E, KURDIHAIDAR B, WANACHIWANAWIN W et al.: Cloning of the glucose-6-phosphate-dehydrogenase gene from Plasmodium falciparum. Mol. Biochem. Parasitol. (1994) 64:313–326.
   PubMed Web of Science ®Google Scholar
• BHISUTTHIBBAN J, PAN X-Q, HOSSLER PA et al.: The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin. J. Biol. Chem. (1998) 273:16192–16198.
   PubMed Web of Science ®Google Scholar
• FLECK SL, ROBINSON BL, PETERS W: The chemotherapy of rodent malaria 54. Combinations of Tenozan B07' (Fenozan-50F), a difluorinated 3, 3'-spirocyclopentane 1, 2, 4-trioxane, with other drugs against drug-sensitive and drug-resistant parasites. Ann. Trop. Med. Parasitol. (1997) 91:33–39.
   PubMed Web of Science ®Google Scholar
• JAMES ER: Superoxide dismutase. Parasitol. Today (1994) 10:481–484.
   PubMedGoogle Scholar
• FARBER PM, ARSCOTT LD, WILLIAMS CH, BECKER K, SCHIRMER RH: Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. FEBS Lett. (1998) 422:311–314.
   PubMed Web of Science ®Google Scholar
• MULLER S, GILBERGER TW, FARBER PM et al.: Recombinant putative glutathione-reductase of Plasmodium falciparum exhibits thioredoxin reductase activity. Mol. Biochem. Parasitol. (1996) 80:215–219.
   PubMed Web of Science ®Google Scholar
• GILBERGER TW, WALTER RD, MULLER S: Identification and characterization of the functional amino acids at the active site of the large thioredoxin reductase from Plasmodium falciparum. J. Biol. Chem. (1997) 272:29584–29589.
   PubMed Web of Science ®Google Scholar
• GILBERGER TW, BERGMANN B, WALTER RD, MULLER S: The role of the C-terminus for catalysis of the large thioredoxin reductase from Plasmodium falciparum. FEBS Lett. (1998) 425:407–410.
   PubMed Web of Science ®Google Scholar
• LUERSEN K, WALTER RD, MULLER S: Glutathione depletion caused by buthionine sulfoximine has an antimalarial effect. 1st COST-B9 Congress on Antiprotozoal Chemotherapy. Granada, Spain (1998).
   Google Scholar
• FAIRLAMB AH, CERAMI A: Metabolism and functions of trypanothione in the Kinetoplastida. Ann. Rev. Microbiol. (1992) 46:695–729.
   PubMed Web of Science ®Google Scholar
• ••An excellent review outlining the historical aspects of the discovery and general backgroundto trypanothione. See [117] for an update.
   Google Scholar
• DUMAS C, OUELLETTE M, TOVAR J et al.: Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages. EMBO J. (1997) 16:2590–2598.
   PubMed Web of Science ®Google Scholar
• TOVAR J, WILKINSON S, MOTTRAM JC, FAIRLAMB AH: Evidence that trypanothione reductase is an essential enzyme in Leishmania by targeted replacement of the tryA gene locus. Mol. Microbiol. (1998) 29:653–660.
   PubMed Web of Science ®Google Scholar
• HUNTER WN: A structure-based approach to drug discovery; crystallography and implications for the development of antiparasite drugs. Parasitology (1997) 114(Suppl.):S17–S29.
   Google Scholar
• SMITH K, NADEAU K, BRADLEY M, WALSH C, FAIRLAMB AH: Purification of glutathionylspermidine and trypanothione synthetases from Crithidia fasciculata. Protein Sci. (1992) 1:874–883.
   PubMed Web of Science ®Google Scholar
• TETAUD E, MANAI F, BARRETT MP et al.: Cloning and characterization of the two enzymes responsible for trypanothione biosynthesis in Crithidia fasciculata. J. Biol. Chem. (1998) 273:19383–19390.
   PubMed Web of Science ®Google Scholar
• MCGONIGLE S, DALTON JP, JAMES ER: Peridoxins: a new antioxidant family. Parasitol. Today (1998) 14:139–145.
   PubMedGoogle Scholar
• SPIES HSC, STEENKAM DJ: Thiols of intracellular pathogens-identification of ovothiol-A in Leishmania donovani and structural-analysis of a novel thiol from Mycobacterium bovis. Eur. J. Biochem. (1994) 224:203–213.
   PubMedGoogle Scholar
• STEENKAMP DJ, SPIES HSC: Identification of a major low molecular mass thiol of the trypanosomatid Crithidia fasciculata as ovothiol A-facile isolation and structural-analysis of the bimane derivative. Eur. J. Biochem. (1994) 223:43–50.
   PubMedGoogle Scholar
• BROWN DM, UP CROFT JA, UP CROFT P: Free radical detoxification in Giardia duodenalis. Mol. Biochem. Parasitol. (1995) 72:47–56.
   PubMed Web of Science ®Google Scholar
• PAGE-SHARP M, BEHM CA, SMITH GD: Tritrichomonas foetus and Trichomonas vaginalis: the pattern of inactivation of hydrogenase activity by oxygen and activities of catalase and ascorbate peroxidase. Microbiology (1996) 142:207–211.
   PubMed Web of Science ®Google Scholar
• ELLIS JE, YARLETT N, COLE D, HUMPHREYS MJ, LLOYD D: Antioxidant defences in the microaerophilic protozoan Trichomonas vaginalis: comparison of metronidazole-resistant and sensitive strains. J. Gen. Microbiol. (1994) 140:2489–2494.
   Google Scholar
• BROWN DM, UPCROFT JA, UP CROFT P: Cysteine is the major low-molecular weight thiol in Giardia duodenalis. Mol. Biochem. Parasitol. (1993) 61:155–158.
   PubMed Web of Science ®Google Scholar
• LUJAN HD, NASH TE: The uptake and metabolism of cysteine by Giardia lamblia trophozoites. J. Euk. Microbiol. (1994) 41:169–175.
   PubMed Web of Science ®Google Scholar
• MILORD F, PEPIN J, LOKO L, ETHIER L, MPIA B: Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness. Lancet (1992) 340:652–655.
   PubMed Web of Science ®Google Scholar
• MCCANN PP, PEGG AE: Ornithine decarboxylase as an enzyme target for therapy. Pharmacol. Ther. (1992) 54:195–215.
   PubMed Web of Science ®Google Scholar
• GHODA L, PHILLIPS MA, BASS KE, WANG CC, COFFINO P: Trypanosome ornithine decarboxylase is stable because it lacks sequences found in the carboxyl terminus of the mouse enzyme which target the latter for intracellular degradation. J. Biol. Chem. (1990) 265:11823–11826.
   PubMed Web of Science ®Google Scholar
• ITEN M, METT H, EVANS A et al.: Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D, L-alpha-difluoromethylornithine. Antimicrob. Agents Chemother. (1997) 41:1922–1925.
   PubMed Web of Science ®Google Scholar
• YARLETT N, MARTINEZ MP, MOHARRAMI MA, TACHEZY J: The contribution of the arginine dihydrolase pathway to energy metabolism by Trichomonas vaginalis. Mol. Biochem. Parasitol. (1996) 78:117–125.
   PubMed Web of Science ®Google Scholar
• YARLETT N, BACCHI C: Polyamine metabolism in anaerobic protozoa. In: Biochemical Protozoology. Coombs GH, North MJ (Eds.), Taylor & Francis, London (1991) :458–468.
   Google Scholar
• KEITHLY JS, ZHU G, UPTON SJ et al.: Polyamine biosynthesis in Cryptosporidium parvum and its implications for chemotherapy. Mol. Biochem. Parasitol. (1997) 88:35–42.
   PubMed Web of Science ®Google Scholar
• ROSENTHAL PJ: Proteases of malaria parasites: new targets for chemotherapy. Emerging Infect. Dis. (1998) 4:49–57.
   PubMed Web of Science ®Google Scholar
• FRANCIS SE, SULLIVAN DJ, GOLDBERG DE: Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Ann. Rev. Microbiol. (1997) 51:97–123.
   PubMed Web of Science ®Google Scholar
• FRANCIS SE, GLUZMAN IY, OKSMAN A, BANERJEE D, GOLBERG DE: Characterisation of native falcipain, an enzyme involved in Plasmodium falciparum hemoglobin degradation. Mol. Biochem. Parasitol. (1996) 83:189–200.
   PubMed Web of Science ®Google Scholar
• FRANCIS SE, GLUZMAN if, OKSMAN A et al.: Molecular characterisation and inhibition of a Plasmodium falciparum aspartic hemoglobinase. EMBO J. (1994) 13:306–317.
   PubMed Web of Science ®Google Scholar
• MOON RP, BUR D, LOETSCHER H et al.: Studies on plasmepsins land II from the malarial parasite Plasmodium falciparum and their exploitation as drug targets. Adv. Exp. Med. Biol. (1998) 436:397–406.
   PubMed Web of Science ®Google Scholar
• ••Good up-to-date account of progress in our understanding of these critical enzymes.
   Google Scholar
• SELZER PM, CHEN XW, CHAN VJ et al.: Leishmania major molecular modeling of cysteine proteases and prediction of new nonpeptide inhibitors. Exp. Parasitol. (1997) 87:212–221.
   PubMed Web of Science ®Google Scholar
• ENGEL JC, DOYLE PS, PALMER J et al.: Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi. J. Cell Sci. (1998) 111:597–606.
   PubMed Web of Science ®Google Scholar
• MOTTRAM JC, BROOKS DR, COOMBS GH: Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions. Curr. Opin. Microbiol. (1998) 1:455–460.
   PubMed Web of Science ®Google Scholar
• MOTTRAM JC, SOUZA AE, HUTCHISON JE et al.: Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors. Proc. Natl. Acad. Sri. USA (1996) 93:6008–6013.
   PubMed Web of Science ®Google Scholar
• COOMBS GH, MOTTRAM JC: Parasite proteinases and amino acid metabolism: possibilities for chemotherapeutic exploitation. Parasitology (1997) 114(Suppl.):S61–S80.
   Google Scholar
• ••Excellent review covering most of what is known on proteinases and key aspects of aminoacid metabolism in protozoa.
   Google Scholar
• VIEIRA LL, LAFUENTE E, GAMARRO F, CABANTCHIK ZI: An amino acid channel activated by hypotonically induced swelling of Leishmania major promastigotes. Biochem. J. (1996) 319:691–697.
   PubMed Web of Science ®Google Scholar
• PEGG AE, MCCANN PP: S-Adenosylmethionine decarboxylase as an enzyme target for therapy. Pharmacol. Ther. (1992) 56:359–377.
   PubMed Web of Science ®Google Scholar
• SUFRIN JR, MESHNICK SR, SPIESS AJ et al.: Methionine recycling pathways and antimalarial drug design. Antimicrob. Agents Chemother. (1995) 39:2511–2515.
   PubMed Web of Science ®Google Scholar
• RISCOE MK, TOWER PA, PEYTON DH, FERRO AJ, FITCHEN JH: Methionine recycling as a target for antiprotozoal drug development. In: Biochemical Protozoology. Coombs GH, North MJ (Eds.), Taylor & Francis, London (1991):450–457.
   Google Scholar
• BERGER BJ, DAI WW, WANG H, STARK RE, CERAMI A: Aromatic amino-acid transamination and methionine recycling in trypanosomatids. Proc. Natl. Acad. Sci. USA (1996) 93:4126–4130.
   PubMed Web of Science ®Google Scholar
• LOCKWOOD BC, COOMBS GH: Purification and characterisation of methionine y-lyase from Trichomonas vaginalis. Biochem. J. (1991) 279:675–682.
   PubMed Web of Science ®Google Scholar
• TETAUD E, BARRETT MP, BRINGAUD F, BALTZ T: Kinetoplastid glucose transporters. Biochem. J. (1997) 325:569–580.
   PubMed Web of Science ®Google Scholar
• ••A review summarising more or less all that is known on the trypanosomatid glucosetransporters and covering general features of why transporters are of great importance to protozoa.
   Google Scholar
• MCCONVILLE MJ, FERGUSON MAJ: The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eucaryotes. Biochem. J. (1993) 294:305–324.
   PubMed Web of Science ®Google Scholar
• SMITH TK, SHARMA DK, CROSSMAN A et al.: Parasite and mammalian GPI biosyntheticpathways can be distinguished using synthetic substrate analogues. EMBO J. (1997) 16:6667–6675.
   PubMed Web of Science ®Google Scholar
• GOLDBERG DE, SHARMA V, OKSAMN A et al.: Probing the chloroquine resistance locus of Plasmodium falciparum with a novel class of multidentate met al(III) coordination complexes. J. Biol. Chem. (1997) 272:6567–6572.
   PubMed Web of Science ®Google Scholar
• CARTER NS, FAIRLAMB AH: Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature (1993) 361:173–176.
   PubMed Web of Science ®Google Scholar
• DE KONING HP, WATSON CJ, JARVIS SM: Characterization of a nucleoside/proton symporter in procyclic Trypanosoma brucei brucei. J. Biol. Chem. (1998) 273:9486–9494.
   PubMed Web of Science ®Google Scholar
• PENNY JI, HALL ST, WOODROW CJ et al.: Expression of substrate-specific transporters encoded by Plasmodium fakiparum in Xenopus laevis oocytes. Mol. Biochem. Parasitol. (1998) 93:81–89.
   PubMed Web of Science ®Google Scholar
• SALIBA KJ, HORNER HA, KIRK K: Transport and metabolism of the essential vitamin pantothenic acid in human erythrocytes infected with the malaria parasite Plasmodium fakiparum. J. Biol. Chem. (1998) 273:10190–10195.
   PubMed Web of Science ®Google Scholar
• KIRK K, HORNER HA, ELFORD BC, ELLORY JC, NEWBOLD CI: Transport of diverse substrates into malaria-infected erythrocytes via a pathway showing functional-characteristics of a chloride channel. J. Biol. Chem. (1994) 269:3339–3347.
   PubMed Web of Science ®Google Scholar
• GERO AM, KIRK K: Nutrient transport pathways in Plasmodium-infected erythrocytes: what and where are they? Parasitol. Today (1994) 10:395–399.
   Google Scholar
• HALDAR K: Ducts, channels and transporters in Plasmodium-infected erythrocytes. Parasitol Today (1994) 10:393–395.
   PubMedGoogle Scholar
• COOMBS GH, VICKERMAN K, SLEIGH MA, WARREN A: Evolutionary Relationships among Protozoa. Kluwer, Dortrecht (1990464.
   Google Scholar